Manipal Health Q1 FY27 Earnings Call — Analysis (NSE: MANIPALHOS)
Manipal Health delivered strong Q1 FY27 revenue growth of 38% YoY to ₹3,091 Cr, driven by volume growth and Sahyadri turnaround, while planning ₹2,000 Cr capex in FY27 to support network expansion.
Result quality: stable — Results context unavailable. Management sentiment: optimistic.
The take
Q1FY27 Revenue from Operations ₹3,091 Cr ( +38% YoY ) . New guidance — FY30 3-4 year capex and bed capacity… ₹4,000 Cr . New story: Volume-led vs price-led care delivery .
Results
Revenue grew 38% YoY to ₹3,091 Cr with network EBITDA of ₹749 Cr (+26% YoY) and EBITDA margin of 24.2% (25.0% ex-Sahyadri).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from Operations | ₹3,091 Cr | +38% | yoy · Q1FY27 |
| Network EBITDA | ₹749 Cr | +26% | yoy · Q1FY27 |
| Network EBITDA Margin | 24.2% | none · Q1FY27 | |
| EBITDA Margin (ex-Sahyadri) | 25.0% | -150 bps | yoy · Q1FY27 |
| Digital Revenue | ₹710 Cr | none · Q1FY27 · 23% of total revenue | |
| ARPOB (ex-Sahyadri) | ₹77,200/day | +9% | yoy · Q1FY27 |
| Sahyadri Revenue | ₹332 Cr | +13% | yoy · Q1FY27 |
| Sahyadri EBITDA | ₹58 Cr | +19% | yoy · Q1FY27 · 17.5% EBITDA margin |
| Q1 FY27 Capex | ₹900 Cr | none · Q1FY27 |
Guidance
Management plans ~₹2,000 Cr capex in FY27 and ~₹4,000 Cr over 3-4 years to add 3,000 beds, while targeting net debt/EBITDA reduction to 0.9x in Q2 FY27 post-IPO debt repayment.
What management committed to
- [Manipal Health Enterprises] will spend around INR4,000 crores of capex in the next 3-4 years as [Manipal Health Enterprises] adds 3,000 beds. — INR4,000 crores, FY30
- [Manipal Health Enterprises] will end up spending almost INR2,000 crores of capex in the current year [FY27]. — almost INR2,000 crores, FY27
- [Manipal Health Enterprises] net debt to EBITDA will go down to 0.9x at quarter 1 level once [Manipal Health Enterprises] repays this debt in Quarter 2 [FY27] using IPO proceeds. — 0.9x, Q2FY27
- [Manipal Health Enterprises] expects [the greenfield hospital in Raipur] to get commissioned in Q4 of FY27. — Q4FY27
- [Manipal Health Enterprises] will temporarily close down [Kinder Hospital Whitefield] for a few months for renovations to remodel it into a multispecialty facility within 8-9 months. — FY27
- [Manipal Health Enterprises] has no plans to bring medical colleges into the listed entity and intends to remain focused on tertiary and quaternary care brick-and-mortar hospitals.
Key themes
Volume-led expansion and acquisition turnaround
How the narrative shifted
- Volume-led vs price-led care delivery: Management emphasizes driving growth primarily through patient volume and short ALOS rather than aggressive tariff increases.
- Sahyadri turnaround and network integration: Replicating past acquisition playbooks in Sahyadri via clinician sharing, digital tools, and acuity mix to expand margins toward network levels.
- High-acuity clinical mix expansion: Aggressively expanding CONGO-R specialty share and complex robotic/quaternary procedures to enhance realization per occupied bed.
- Micro-market clustering in key metros: Consolidating metro presence (Bangalore, Pune, Kolkata) through bolt-on sub-100 bed assets and greenfields acting as hub-and-spoke networks.
- Government scheme transition in East cluster: Managing the transition in regional government health scheme mix in West Bengal by accelerating cash and TPA channel growth.
Operational commentary
- Added 103 brownfield beds and advanced oncology equipment (linear accelerator and PET-CT) at Nashik hospital, taking licensed capacity to 307 beds.
- Commissioned 50th hospital with ~300 beds in Electronic City, Bangalore in July 2026, expanding Bangalore licensed bed capacity to nearly 3,000 beds across 13 facilities.
- Announced asset and operations acquisition of 100-bed Kinder Hospital in Whitefield, Bangalore; facility will be temporarily closed for 6-7 months to remodel into a multispecialty tertiary center.
- High-acuity Centres of Excellence (CONGO-R) revenue contribution expanded to 65% in Q1 FY27, with IP revenues across these specialties up 45% YoY.
- Greenfield Bangalore units (Kanakapura and Yelahanka) reached EBITDA break-even within 5 months and 2 months respectively, delivering a combined 13% EBITDA margin in Q1 FY27.
- Sahyadri Hospitals integration on track over an 18-month roadmap; doctor interoperability initiated across 58 clinicians in Pune with brand transition underway.
Analyst Q&A
Q. What is the strategy and timeline to bridge the margin gap between Sahyadri Hospitals (~17.5%) and the corporate average (~25%)?
Integration is planned over 16-18 months using a standardized playbook involving clinician interoperability across 9 Pune units, infrastructure upgrades, digital integration, and improving case complexity in high-acuity specialties (CONGO-R).
Q. What caused the ex-Sahyadri margin compression YoY and what is the outlook on margin trajectory?
Compression was driven by a 60 bps base effect from a one-off ₹15 Cr contractual gain in Q1 FY26, ~50 bps drag from fully staffed doctor costs at new Bangalore greenfields, and slower government scheme collections; margins will expand as greenfields ramp up.
Q. Will Manipal enter medical college operations under the new for-profit regulatory framework?
Management explicitly ruled this out, stating the listed entity will remain exclusively focused on tertiary and quaternary brick-and-mortar hospitals.
Q. What is the rationale for acquiring a sub-100 bed asset like Kinder Hospital?
The asset provides immediate capacity in the fast-growing Whitefield micro-market where Manipal already operates two large hub hospitals; it will be remodeled into a multispecialty center without relying on stand-alone mother/child economics.
Research and educational content only. Not investment advice.